The Galacto-Oligosaccharide Market is being driven by Increasing need for supplementary nutrients among infants
The Galacto-Oligosaccharide Market is expected to grow at a CAGR of 11.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 916.5 million. In the realm of nutraceuticals, these functional food products are primarily utilized for therapeutic purposes while offering essential nutritional benefits. They provide physiological advantages, shielding against chronic diseases and lifestyle disorders, such as obesity and cardiovascular diseases. Nutraceuticals have gained significant traction in the healthcare sector due to their potential nutritional, safety, and therapeutic properties. Prebiotics, a major category within nutraceuticals, holds substantial importance. Among prebiotics, galacto-oligosaccharides (GOS) are noteworthy for their extensive applications. These non-digestible carbohydrates offer a sweet taste to food without elevating blood glucose levels in diabetic individuals, making them suitable sweeteners. Moreover, GOS play a crucial role in maintaining gut health by promoting the growth of beneficial bacteria, thereby contributing to overall wellness.
Get more information on Galacto-Oligosaccharide Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
215 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.3% |
Market growth 2025-2029 |
USD 916.5 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
10.4 |
Key countries |
US, Germany, France, China, UK, The Netherlands, Canada, Japan, Italy, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Galacto-Oligosaccharide (GOS) market encompasses human milk oligosaccharides (HMOs), which offer various health benefits. These include influencing bacterial adherence, enhancing gut microbiota composition, boosting immune response, reducing inflammation, and ensuring digestive comfort. Additionally, they facilitate mineral absorption, exhibit synbiotic effect, possess antioxidant capacity, and interact with food matrices. Dosage optimization, processing technology, and quality control are crucial for their application in foods. Health benefits assessment is based on clinical studies, metabolic effects, in vitro fermentation, and in vivo studies. Prebiotic classification, structure-function relationship, receptor binding, microbial colonization, fermentation kinetics, production cost, and yield optimization are other essential aspects.
The Galacto-Oligosaccharide market is a significant segment within the larger pharmaceuticals industry, focusing on the production and research of prebiotic fibers, particularly those used for gut microbiome modulation. This market encompasses companies involved in the R&D and manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, as well as veterinary medicines. According to Technavio, the global pharmaceuticals market is projected to grow substantially due to demographic trends, such as the increasing population aged 60 and above. By 2030, Europe and the US are predicted to have approximately one-quarter of their populations in this age group. This demographic shift will drive demand for pharmaceutical solutions, including those related to Galacto-Oligosaccharides, as the aging population requires more healthcare services and medications. Additionally, advancements in oligosaccharide synthesis and lactose fermentation technologies are expected to contribute to market growth.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted